Menu
November 1, 2023 : Embolx Inc., a leading medical technology company, and Girlow USA, a leading distributor of medical devices and supplies, have announced a partnership to expand the distribution of Embolx’s products into South America. The partnership will leverage Girlow’s extensive relationships and expertise in the South American market to bring Embolx’s innovative products to more patients and healthcare providers in the region.
Embolx develops and manufactures medical devices for the treatment of embolic stroke, a serious type of stroke that is caused by a blood clot blocking an artery in the brain. Physicians use Embolx’s products to remove blood clots and restore blood flow to the brain, which can help prevent serious brain damage and disability.
Girlow USA is a leading distributor of medical devices and supplies in the United States and Latin America. The company has a strong track record of bringing new and innovative medical technologies to market. Girlow’s network of relationships with healthcare providers and distributors in South America will be instrumental in expanding the reach of Embolx’s products in the region.
The partnership between Embolx and Girlow USA is a positive development for companies and patients in South America. Embolx will benefit from Girlow’s expertise in the South American market and its relationships with healthcare providers and distributors. Girlow will benefit from the opportunity to distribute Embolx’s innovative products, which are in high demand in South America.
Patients in South America will benefit from having access to Embolx’s products, which can help to improve the outcomes of embolic stroke treatment. The partnership is also expected to create jobs and boost the economies of the countries in which Embolx and Girlow operate.
Embolx Inc. and Girlow USA have partnered to expand the distribution of Embolx’s products into South America. The partnership is expected to benefit both companies and patients in South America. Embolx will benefit from Girlow’s expertise in the South American market and its relationships with healthcare providers and distributors. Girlow will benefit from the opportunity to distribute Embolx’s innovative products, which are in high demand in South America. Patients in South America will benefit from having access to Embolx’s products, which can help to improve the outcomes of embolic stroke treatment.
